Advances in phage display technology for drug discovery

Area of Science:

• Biotechnology
• Molecular Biology
• Drug Discovery

Background:

• Library-based methods mimic natural evolution to identify ligand-target interactions.
• Phage display technology is a key tool for screening and discovering ligands with high binding affinities.
• This method has broad applications in addressing challenges within novel drug discovery.

Purpose of the Study:

• To review recent advancements in phage display technology for identifying novel bioactive compounds.
• To discuss the use of phage display in producing proteins and peptides.
• To explore the potential of phage display in reducing reliance on traditional antibodies.

Main Methods:

• Review of recent literature on phage display technology.
• Analysis of applications in protein and peptide production.
• Examination of phage display's role in generating antibody fragments (e.g., antigen-binding fragments, single-chain fragment variables, VHHs).

Main Results:

• Phage display is effective in discovering novel bioactive compounds.
• The technology facilitates the production of therapeutic proteins and peptides.
• It offers an alternative to conventional antibody development, enabling the creation of specific antibody fragments.

Conclusions:

• Phage display-derived products are vital for disease diagnosis and treatment.
• The technology is integral to the drug development pipeline, with significant future growth expected.
• Widespread applications are predicted in biosensing, molecular imaging, gene therapy, vaccine development, and nanotechnology.